Physicians News

Cervical Cancer: FG to commence HPV immunisation on national scale by 2021

The Federal Government says it will commence immunisation against Human Papilloma Virus (HPV) for cervical cancer in 2021.

Dr Faisal Shuaib, the Executive Director, National Primary Health Care Development Agency (NPHCDA), made this known at a Virtual National Stakeholders’ Forum on the Elimination of Cervical Cancer on Friday.

The virtual meeting  was organised by the National Cancer Control Programme (NCCP) of the Federal Ministry of Health (FMoH) in collaboration with the Johns Hopkins Bloomberg School of Public Health International Vaccine Access Centre and Direct Consulting and Logistics.

Shuaib said the immunisation would be on a national scale by first quarter of 2021 to eliminate cervical cancer.

According to him, what should concern stakeholders is how to eliminate barriers to availability of HPV vaccine that has been around for over 10 years.

He said “we have to crush the barriers that prevent us from accessing this vaccine, such as HPV when it is available anywhere in the world.

“Africa should not always wait for decades to get solution that is available globally, not just in Africa but in Nigeria specifically.

“We at the NPHCDA are committed; we are committed to deliver HPV vaccine to our communities,” he said.

The executive director added that the agency was determined to the final stretch of getting vaccine to the people, and that nothing could stop from achieving that.

“It took a long time for us to get here, we are going to finish and cross the line like we did for polio eradication last week.

“The Federal Ministry of Health, in collaboration with the NPHCDA, is in the forefront of driving local vaccine production through our joint venture agreement with May and Baker.

“It is one of the interventions that FMoH is putting in place to make sure that we don’t need to wait for decades to prevent such terrible disease,” he said.

Shuaib said the agency had improved routine immunisation in the past two years, doubling coverage from 32 per cent in 2016 to 67 per cent in 2019.

“You can be sure that once we introduce HPV vaccine in the first quarter 2021, we will ramp up coverage in the first approach.

“It is not just vaccine that matters, we are introducing as part of our post COVID-19 strategy, we are ramping up our pre-cancer screening in primary health care centres.

“We are building the capacity of primary health workers so that they will be able to carry out simple screening and breast examination for breast cancer.

“But also on annual basis, we are trying to build the capacity of health workers so that they can do simple examinations of the cervix if there is any indication that they are abnormal.

“The workers will then be able to encourage women to do Pap Smear test on annual basis.”

The executive director said NPHCDA was passionate about so many things, noting that “introducing vaccine against cervical cancer and other cancers is a priority for us.

“It is priority and ensuring screening for cervical cancer is a model we are introducing as re-emerging in the Post COVID-19 era.”

He commended Dr Zainab Bagudu, the founder of Medicaid Cancer Foundation for her advocacy work on cancer.

Bagudu, the First Lady of Kebbi, in her remarks said the world was moving toward elimination of cancer and that Nigeria should not be left behind.

She said that “for us in Kebbi, we may not have high technology, but we have the awareness and the human resources at Primary Health Care centres.

“We are waiting for the vaccine to commence and support our work in that area, and we will be pleased to partner with all to achieve our goals.”

Dr Chizoba Wonodi of the John Hopkins International Vaccine Access Centre (IVAC), said the objectives of the meeting was to share latest updates on the global push toward the elimination of cancer and promote increased understanding of the roles and responsibilities of stakeholders at all levels.

The meeting was also to review progress on the challenges to achieving the objectives set out in the National Strategic Plan and to proffer solutions to address the challenges in implementing the plan, she said.

The News Agency of Nigeria (NAN) reports that the forum is planned to hold in two phases; the virtual phase and later an in-person phase after the COVID-19 lockdown is fully lifted.

Cervical cancer is a deadly disease that affects over 14,000 women and 8,000 deaths due to late presentation at health facilities annually, making it the second leading cause of cancer death in women aged 15 to 44 years in Nigeria.

The main cause of cervical cancer is the Human Papilloma Virus (HPV).

Evidence showed  that HPV could  be eliminated using three interventions: HPV vaccination, screening for pre-cancerous lesions and, treatment of invasive cancer.




About the author

Joseph Chukwuma Oputa

Joseph Chukwuma Oputa is the Managing Editor of Maslow Businessnews and Physicians News publications published by Maslow Business News Publications, Lagos, Nigeria.

Joseph Oputa is a proud Alumnus of the prestigious Nigerian Institute of Journalism, Lagos and Federal Polytechnic, Bida, Niger State.

Leave a Comment